Indefinite Delivery Contract 75N95025D00007
Award Date
5/15/25
Last Date to Order
5/14/30
Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) is a single-award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development organization. The contract, valued at a ceiling of $342,897, is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES over a 5-year period of performance from September 27, 2021 to April 25, 2025. The contract was not set aside for any specific business size or socioeconomic...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. federal government, to In Vitro Strategies Limited Liability Company, a woman-owned small business. The contract has a total ceiling value of $187,438.64 and was set aside for small businesses. The purpose of this IDC is to provide in-vitro research and related services to support NIDA's mission. While the full scope of contracted work is not detailed, the...
The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded an Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide synthesis and distribution services for drugs of abuse and related compounds. The contract has a ceiling value of $14,004,330 and a period of performance from June 9, 2022 to June 8, 2027. This contract supports NIDA's mission of conducting...
This indefinite delivery contract (IDC) was awarded by a U.S. federal government agency to IIT Research Institute (IITRI), a non-profit contract research organization. The IDC is a multiple-award vehicle with a $0 ceiling value and an ultimate completion date of September 30, 2007. Under this IDC, IITRI provides a range of preclinical research services to support federal agencies such as the National Institutes of Health (NIH), including the National Cancer Institute (NCI), National Institute of...
This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The contract has a ceiling value of $48,882,666.00 and a period of performance through August 5, 2030. The purpose of this IDC is to obtain pharmacology studies, animal model development, and related services to support NCATS' Division of Preclinical Innovation drug...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Emmes Company LLC, a for-profit limited liability company, to serve as the NIDA Data, Statistics, and Clinical Trial Support Center. Under this single-award IDIQ contract valued up to $31.2 million over a five-year period from September 2022 to September 2027, The...
This federal Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to the University of Pittsburgh. The $2,053,689.26 single-award contract funds a study on mental health and trauma (DSIR program) and does not have any set-aside designations. Under this IDC, the University of Pittsburgh is responsible for providing various preclinical models and specialized reagents to support the...
The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a single-award Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, for the preparation and distribution of research drug products. The $19,975,000 contract has a period of performance from March 20, 2025 to March 19, 2029, with a final completion date of March 19, 2026 for the initial $1,497,865 delivery order. RTI International, an experienced...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to New York University (NYU) School of Medicine. The $898,929.74 contract provides funding for an MTA (Mental Health Services Study) study under the DSIR (Drug Dependence Epidemiology Research) program. As an IDC, this contract provides a flexible mechanism for NIDA to issue task...
This indefinite delivery contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to the Research Foundation for Mental Hygiene, Inc. (RFMH) doing business as RFMH. The single-award IDC has a ceiling value of $1,749,352.30 and a period of performance ending on June 30, 2013. The purpose of this IDC is to provide funding and support for an MTA (Mental Health...